2024 Global Clinical Chemistry and Immunodiagnostics Market: Unmet Needs, Supplier Shares and Strategies, Segment Volume and Sales Forecasts for 100 Tests, Emerging Technologies and Trends, Instrumentation Pipeline, Growth Opportunities

August 2024 | - | ID: 2800FF62C39FEN
Venture Planning Group

Abstracts

The new seven-country market intelligence and technology assessment study from LeadingMarketResearch.com was designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and develop effective strategic responses. The report explores future trends in the U.S., five major European countries (France, Germany, Italy, Spain, UK) and Japan; provides estimates of the specimen, test and sales volumes, as well as major supplier sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years.The report is available by section, and can be customized to specific information needs and budget.The clinical chemistry and immunodiagnostics markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. ; Some segments, like routine chemistry, begin to resemble commodity markets, where product positioning and cost per test are more critical than underlying technology. ; This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.The report contains 1,200 pages, 500 tables, and presents:Major issues pertaining to the global clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.Five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in US hospitals, commercial laboratories, and physician offices, including controls, calibrators and consumables.Five-year volume forecasts for serum, whole blood, plasma, CFS, urine and other specimens.Five-year reagent and instrument sales forecasts.Review of current instrumentation technologies, and a feature comparison of high-, medium-, and low-volume/POC analyzers.Sales and market shares of leading reagent and instrument suppliers.Review of current and emerging technologies and their potential market applications.Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables.Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.Market penetration strategies, entry barriers and risks.

Contents

I. Introduction
II. Worldwide Market Overview

1. BUSINESS ENVIRONMENT

2. MARKET STRUCTURE

3. MARKET SIZE AND GROWTH

III. Major Product Development Opportunities
A. Blood Typing and Grouping
B. Infectious Disease Screening
C. Auxiliary
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
VI. Worldwide Technology and Market Overview
A. Major Blood Typing, Grouping and Infectious
Disease Screening Tests

1. BLOOD TYPING AND GROUPING TESTS

a. ABO
b. Antibody Panels
c. Antibody Screening
d. Antigen Typing
e. Antiglobulin Test
Table of Contents (continues)
f. Crossmatch
g. HLA Typing
h. Rh
i. Other Blood Groups

2. INFECTIOUS DISEASE SCREENING TESTS

a. AIDS/HIV
- Background
- Diagnostic Tests
° Enzyme Immunoassay
° Viral Load/Drug Resistance Testing
° Genotype and Phenotype Testing
- Blood Banking Considerations
b. Hepatitis Markers
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Hepatitis D (Delta Hepatitis)
- Hepatitis E
- Hepatitis G
- Vaccines and Drugs
c. Cytomegalovirus
- Background
- Diagnostic Tests
- Vaccines and Drugs
d. Syphilis
- Background
- Diagnostic Tests
- Vaccines and Drugs
e. West Nile Virus
- Background
- Clinical Syndromes
- Diagnostic Tests
- Vaccines and Drugs
f. Parvovirus B19
- Microbiology
- Epidemiology
- Clinical Syndromes
- Diagnostic Test
- Vaccines and Drugs